PL435353A1 - Formulation of freeze-dried eggs of Helix aspersa maxima snails and an aqueous extract of this formulation, as well as method of their preaparation and application - Google Patents
Formulation of freeze-dried eggs of Helix aspersa maxima snails and an aqueous extract of this formulation, as well as method of their preaparation and applicationInfo
- Publication number
- PL435353A1 PL435353A1 PL435353A PL43535320A PL435353A1 PL 435353 A1 PL435353 A1 PL 435353A1 PL 435353 A PL435353 A PL 435353A PL 43535320 A PL43535320 A PL 43535320A PL 435353 A1 PL435353 A1 PL 435353A1
- Authority
- PL
- Poland
- Prior art keywords
- formulation
- aqueous extract
- snails
- maxima
- freeze
- Prior art date
Links
- 239000006286 aqueous extract Substances 0.000 title abstract 3
- 241000330927 Helix aspersa maxima Species 0.000 title abstract 2
- 235000013601 eggs Nutrition 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 2
- 239000000203 mixture Substances 0.000 title 2
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Przedmiotem wynalazku jest preparat z liofilizowanych jaj ślimaków H. aspersa maxima i jego wodny ekstrakt jako ważne źródła naturalnych związków wykazujących działanie przeciwnowotworowe, zwłaszcza w terapiach kombinowanych. Przedmiotem wynalazku jest również sposób otrzymywania preparatu i jego wodnego ekstraktu oraz ich terapeutyczne zastosowanie w leczeniu nowotworu jelita grubego.The subject of the invention is the preparation of freeze-dried eggs of H. aspersa maxima snails and its aqueous extract as important sources of natural compounds showing antitumor activity, especially in combination therapies. The subject of the invention is also a method of obtaining the preparation and its aqueous extract and their therapeutic use in the treatment of colorectal cancer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL435353A PL245518B1 (en) | 2020-09-18 | 2020-09-18 | Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa maxima snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL435353A PL245518B1 (en) | 2020-09-18 | 2020-09-18 | Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa maxima snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL435353A1 true PL435353A1 (en) | 2022-03-21 |
| PL245518B1 PL245518B1 (en) | 2024-08-19 |
Family
ID=80739279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL435353A PL245518B1 (en) | 2020-09-18 | 2020-09-18 | Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa maxima snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL245518B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL443639A1 (en) * | 2023-01-31 | 2024-08-05 | Uniwersytet Śląski W Katowicach | Condensate from Cornu aspersum snail eggs, method of its production and use, and a cosmetic composition based on condensate from Cornu aspersum snail eggs |
-
2020
- 2020-09-18 PL PL435353A patent/PL245518B1/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL443639A1 (en) * | 2023-01-31 | 2024-08-05 | Uniwersytet Śląski W Katowicach | Condensate from Cornu aspersum snail eggs, method of its production and use, and a cosmetic composition based on condensate from Cornu aspersum snail eggs |
Also Published As
| Publication number | Publication date |
|---|---|
| PL245518B1 (en) | 2024-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123586T1 (en) | SUBCUTANEOUS HER2 ANTIBODY PREPARATIONS | |
| CY1125772T1 (en) | MACROCYCLIC COMPOUNDS FOR THE THERAPEUTIC TREATMENT OF DISEASES | |
| BR112019000598A2 (en) | rna for cancer therapy | |
| MX2020009773A (en) | Combination therapy. | |
| CY1123666T1 (en) | MEDICINAL COMPOUNDS | |
| PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
| CO2022002573A2 (en) | Antibodies against ilt2 and their use | |
| WO2019197605A3 (en) | Drug combinations for use in the treatment of ras-mutant cancer | |
| ZA201907225B (en) | Treatment of her2 positive cancers | |
| CY1122818T1 (en) | 3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPE1PO-[4.5]-DECANE DERIVATIVES | |
| NO20071426L (en) | Cancer combination therapy including AZD2171 and Imatinib | |
| MX420412B (en) | PLINABULIN, COMPOSITIONS COMPRISING IT AND THEIR USES IN THE TREATMENT OF CANCER ASSOCIATED WITH EGFR MUTATION. | |
| CY1123366T1 (en) | 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | |
| CY1111565T1 (en) | ZD6474 5-FU AND / OR CPT-11 COMBINATION TREATMENT | |
| BR112015026247A2 (en) | methods for cancer treatment using tor kinase inhibitor combination therapy | |
| EA202090741A1 (en) | CONJUGATES OF ANTIBODY TO TISSUE FACTOR AND DRUG AND THEIR APPLICATION IN TREATMENT OF CANCER | |
| CY1122923T1 (en) | 3-((HETERO-)ARYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | |
| MX2021015533A (en) | Anti-mesothelin antibodies and immunoconjugates thereof. | |
| MX392779B (en) | ANTI-CD27 ANTIBODIES | |
| EA202091112A1 (en) | SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION | |
| EA202191165A1 (en) | ELACESTRANT IN COMBINATION WITH ABEMACYCLIBUS IN WOMEN WITH BREAST CANCER | |
| EA201792294A1 (en) | COMBINED TREATMENT (OPTIONS) WITH THE USE OF SERIBANTUMAB | |
| MX2018008640A (en) | DERIVATIVES OF 3- (CARBOXIETIL) -8-AMINO-2-OXO-1,3-DIAZA-ESPIRO- [4.5] - DECANO. | |
| MX2023006087A (en) | Lyophilized formulations of tegavivint. | |
| PL435352A1 (en) | Formulation of freeze-dried eggs of Helix aspersa aspersa snails and an aqueous extract of this preparation, as well as method of their preparation and application |